U.S. Supreme Court Upholds Nitric Oxide Patent Win for Linde
Linde Commits to Support Inhaled Nitric Oxide Clinical Studies Relating to COVID-19
(PresseBox) (Guildford, UK, )"Nitric oxide is truly a unique and beneficial drug product. We are proud to be doing our part to support healthcare institutions around the world with a reliable, competitive and beneficial supply of inhaled nitric oxide along with our other medical gases and services," said Ben Glazer, President, US Packaged & Specialty Gases.
Linde is actively supporting doctors as they investigate the use of nitric oxide to treat COVID-19 patients globally. This includes supplying nitric oxide to Massachusetts General Hospital to support a trial launched by their researchers to test the drug's effectiveness for preventing disease progression in patients with mild to moderate disease, thereby avoiding the need for ventilation. Separately, German authorities have authorized on a temporary basis the use of inhaled nitric oxide specifically to treat patients with severe cases of COVID-19